Pierre Bourdage

Chief Commercial Officer

In the Chief Commercial Officer position, Pierre Bourdage has leadership responsibility for the overall Sandoz pipeline strategy and choices, BD&L priorities and decisions, and end-to-end new product value delivery. 

During his time at Sandoz, Pierre has redefined the global strategy across clear therapy areas including complex and underserved biologics. He launched an integrated new portfolio process that drives portfolio selection and evaluation, including adding five biosimilars to pipeline in less than 9 months. Sandoz now has eight approved biosimilars in total, including three that were launched in 2018, and continues to invest and expand a leading biosimilar pipeline.  

Off-patent medicines offer a huge potential and opportunity to bring value by increasing access for patients to affordable medicines, reducing inequalities in healthcare provision and delivering savings to healthcare systems that can be reinvested to support better patient outcomes.

Pierre brings considerable experience in launch excellence and team leadership as well as brand and franchise management with over 20 years in the pharmaceutical and healthcare industry. He has a passion for engaging and mobilizing high performing matrixed teams and is skilled at developing clear and fluid strategic plans that create and sustain value.

Nationality: Canadian | Year of birth: 1979

Professional experience

  • Global Head Sandoz Biopharmaceuticals Business Unit (2019–2022)
  • Head Strategy, Portfolio, BD&L Sandoz Biopharmaceuticals Business Unit (2018–2019)
  • General Manager / Managing Director, Alcon UK & Ireland, a Novartis Division (2015–2018)
  • Vice President Neuroscience & Multiple Sclerosis Specialty Franchise, Novartis Pharmaceuticals Canada Inc. (2012–2015)
  • Vice President Primary Care & Established Medicines Business Franchise, Novartis Pharmaceuticals Canada Inc. (2011–2012)
  • Group Marketing Director Primary Care, Novartis Pharmaceuticals Canada Inc. (2009–2011)
  • Senior Brand Manager Specialty Franchise (2006–2009)
  • Brand Manager Wound & Skin Care, ConvaTec; Bristol Myers Squibb Inc. (2005–2006)
  • Business Analyst Neuroscience & Immunology Specialty Franchise, Novartis Pharmaceuticals Canada Inc. (2004–2005)
  • Sales representative, Novartis Pharmaceuticals Canada Inc. (2002–2004)


  • Post Graduate Certificate in Leadership Capability, with distinction, Glasgow Caledonian University, UK
  • Bachelor of Commerce with distinction, Concordia University, Canada